Those with an elevated prostate-specific antigen test are referred for a biopsy of their prostate to help diagnose prostate cancer or other prostate concerns. This can bring anxiety and discomfort for the patient.

Dr. Chad Ellimoottil, a urologist and division chief of men’s health and reconstruction at Michigan Medicine, shares information on prostate biopsies. He discusses those who need it, forms of biopsy, and the latest in performing them.

For more episodes, visit the Cancer Aware podcast website.

A transcript of this episode can be found here.

Participant

Chad Ellimoottil, MD

Additional Resources

Prostate-specific antigen test

Prostate cancer

Cancer Aware is a part of the Michigan Medicine Podcast Network and is produced by the Michigan Medicine Department of Communication. You can listen to Cancer Aware wherever you get your podcasts.

Hosted on Acast. See acast.com/privacy for more information.

When treating for localized prostate cancer, surgery and radiation are usually what people hear about. However, there are other treatments that could be options under a heading of focal therapy.

Dr. Andrew Wood, a urologic oncologist with the University of Michigan Health Rogel Cancer Center’s Weiser Center for Prostate Cancer talks about these options and which patients could benefit from them.

Participant

Andrew Wood, MD

You can learn more about Cancer Aware on our website.

A transcript of this episode can be found here.

Cancer Aware is a part of the Michigan Medicine Podcast Network and is produced by the Michigan Medicine Department of Communication. You can subscribe to Cancer Aware on Apple Podcasts, Spotify, or wherever you listen to podcasts.

Hosted on Acast. See acast.com/privacy for more information.

Four University of Michigan faculty members have served as president of the American Society of Clinical Oncology, a rare distinction that only two other institutions can claim. ASCO is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

In this episode, Nicole Fawcett, director of communications for the Rogel Cancer Center, sat down with four past ASCO Presidents and talked about the importance of the society, the impact it has had on cancer care and research as a whole and the impact here at U-M.

Participants:

Allen Lichter, MD, FASTRO

Doug Blayney, MD

Dan Hayes, MD

Lori Pierce, MD

You can learn more about Cancer Aware on our website.

A transcript of this episode can be found here.

Cancer Aware is a part of the Michigan Medicine Podcast Network and is produced by the Michigan Medicine Department of Communication. You can subscribe to Cancer Aware on Apple Podcasts, Spotify, or wherever you listen to podcasts.

Hosted on Acast. See acast.com/privacy for more information.